Company page

Hemogenyx Pharmaceuticals Plc

Hemogenyx Pharmaceuticals Plc, trading under the ticker HEMO, is a public company based in the UK with a market capitalization of approximately £71.57 million. The company focuses on developing innovative therapies for blood diseases and related conditions. Hemogenyx is dedicated to advancing its research and clinical programs to address unmet medical needs in the field of hematology.